The Cancer Registry Software market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Cancer Registry Software size is estimated to be USD 57 million in 2026 from USD 45 million in 2020, with a change XX% between 2020 and 2021. The global Cancer Registry Software market size is expected to grow at a CAGR of 6.1% for the next five years.
Market segmentation
Cancer Registry Software market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Cloud-Based
On-Premise
Market segment by Application, can be divided into
Hospitals
Government Organizations
Cancer Research Centers
Others
Market segment by players, this report covers
Onco Inc
Rocky Mountain Cancer Data Systems (RMCDS)
Electronic Registry Systems (ERS)
Mckesson
C/Net Solutions
Elekta AB
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Cancer Registry Software
1.2 Classification of Cancer Registry Software by Type
1.2.1 Overview: Global Cancer Registry Software Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Cancer Registry Software Revenue Market Share by Type in 2020
1.2.3 Cloud-Based
1.2.4 On-Premise
1.3 Global Cancer Registry Software Market by Application
1.3.1 Overview: Global Cancer Registry Software Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Government Organizations
1.3.4 Cancer Research Centers
1.3.5 Others
1.4 Global Cancer Registry Software Market Size & Forecast
1.5 Global Cancer Registry Software Market Size and Forecast by Region
1.5.1 Global Cancer Registry Software Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Cancer Registry Software Market Size by Region, (2016-2021)
1.5.3 North America Cancer Registry Software Market Size and Prospect (2016-2026)
1.5.4 Europe Cancer Registry Software Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Cancer Registry Software Market Size and Prospect (2016-2026)
1.5.6 South America Cancer Registry Software Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Cancer Registry Software Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Cancer Registry Software Market Drivers
1.6.2 Cancer Registry Software Market Restraints
1.6.3 Cancer Registry Software Trends Analysis
2 Company Profiles
2.1 Onco Inc
2.1.1 Onco Inc Details
2.1.2 Onco Inc Major Business
2.1.3 Onco Inc Cancer Registry Software Product and Solutions
2.1.4 Onco Inc Cancer Registry Software Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Onco Inc Recent Developments and Future Plans
2.2 Rocky Mountain Cancer Data Systems (RMCDS)
2.2.1 Rocky Mountain Cancer Data Systems (RMCDS) Details
2.2.2 Rocky Mountain Cancer Data Systems (RMCDS) Major Business
2.2.3 Rocky Mountain Cancer Data Systems (RMCDS) Cancer Registry Software Product and Solutions
2.2.4 Rocky Mountain Cancer Data Systems (RMCDS) Cancer Registry Software Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Rocky Mountain Cancer Data Systems (RMCDS) Recent Developments and Future Plans
2.3 Electronic Registry Systems (ERS)
2.3.1 Electronic Registry Systems (ERS) Details
2.3.2 Electronic Registry Systems (ERS) Major Business
2.3.3 Electronic Registry Systems (ERS) Cancer Registry Software Product and Solutions
2.3.4 Electronic Registry Systems (ERS) Cancer Registry Software Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Electronic Registry Systems (ERS) Recent Developments and Future Plans
2.4 Mckesson
2.4.1 Mckesson Details
2.4.2 Mckesson Major Business
2.4.3 Mckesson Cancer Registry Software Product and Solutions
2.4.4 Mckesson Cancer Registry Software Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Mckesson Recent Developments and Future Plans
2.5 C/Net Solutions
2.5.1 C/Net Solutions Details
2.5.2 C/Net Solutions Major Business
2.5.3 C/Net Solutions Cancer Registry Software Product and Solutions
2.5.4 C/Net Solutions Cancer Registry Software Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 C/Net Solutions Recent Developments and Future Plans
2.6 Elekta AB
2.6.1 Elekta AB Details
2.6.2 Elekta AB Major Business
2.6.3 Elekta AB Cancer Registry Software Product and Solutions
2.6.4 Elekta AB Cancer Registry Software Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Elekta AB Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Cancer Registry Software Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Cancer Registry Software Players Market Share
3.2.2 Top 10 Cancer Registry Software Players Market Share
3.2.3 Market Competition Trend
3.3 Cancer Registry Software Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Cancer Registry Software Revenue and Market Share by Type (2016-2021)
4.2 Global Cancer Registry Software Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Cancer Registry Software Revenue Market Share by Application (2016-2021)
5.2 Cancer Registry Software Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Cancer Registry Software Revenue by Type (2016-2026)
6.2 North America Cancer Registry Software Revenue by Application (2016-2026)
6.3 North America Cancer Registry Software Market Size by Country
6.3.1 North America Cancer Registry Software Revenue by Country (2016-2026)
6.3.2 United States Cancer Registry Software Market Size and Forecast (2016-2026)
6.3.3 Canada Cancer Registry Software Market Size and Forecast (2016-2026)
6.3.4 Mexico Cancer Registry Software Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Cancer Registry Software Revenue by Type (2016-2026)
7.2 Europe Cancer Registry Software Revenue by Application (2016-2026)
7.3 Europe Cancer Registry Software Market Size by Country
7.3.1 Europe Cancer Registry Software Revenue by Country (2016-2026)
7.3.2 Germany Cancer Registry Software Market Size and Forecast (2016-2026)
7.3.3 France Cancer Registry Software Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Cancer Registry Software Market Size and Forecast (2016-2026)
7.3.5 Russia Cancer Registry Software Market Size and Forecast (2016-2026)
7.3.6 Italy Cancer Registry Software Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Cancer Registry Software Revenue by Type (2016-2026)
8.2 Asia-Pacific Cancer Registry Software Revenue by Application (2016-2026)
8.3 Asia-Pacific Cancer Registry Software Market Size by Region
8.3.1 Asia-Pacific Cancer Registry Software Revenue by Region (2016-2026)
8.3.2 China Cancer Registry Software Market Size and Forecast (2016-2026)
8.3.3 Japan Cancer Registry Software Market Size and Forecast (2016-2026)
8.3.4 South Korea Cancer Registry Software Market Size and Forecast (2016-2026)
8.3.5 India Cancer Registry Software Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Cancer Registry Software Market Size and Forecast (2016-2026)
8.3.7 Australia Cancer Registry Software Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Cancer Registry Software Revenue by Type (2016-2026)
9.2 South America Cancer Registry Software Revenue by Application (2016-2026)
9.3 South America Cancer Registry Software Market Size by Country
9.3.1 South America Cancer Registry Software Revenue by Country (2016-2026)
9.3.2 Brazil Cancer Registry Software Market Size and Forecast (2016-2026)
9.3.3 Argentina Cancer Registry Software Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Cancer Registry Software Revenue by Type (2016-2026)
10.2 Middle East & Africa Cancer Registry Software Revenue by Application (2016-2026)
10.3 Middle East & Africa Cancer Registry Software Market Size by Country
10.3.1 Middle East & Africa Cancer Registry Software Revenue by Country (2016-2026)
10.3.2 Turkey Cancer Registry Software Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Cancer Registry Software Market Size and Forecast (2016-2026)
10.3.4 UAE Cancer Registry Software Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Cancer Registry Software Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Cancer Registry Software Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Cancer Registry Software Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Cancer Registry Software Revenue (USD Million) by Region (2016-2021)
Table 5. Global Cancer Registry Software Revenue Market Share by Region (2021-2026)
Table 6. Onco Inc Corporate Information, Head Office, and Major Competitors
Table 7. Onco Inc Major Business
Table 8. Onco Inc Cancer Registry Software Product and Solutions
Table 9. Onco Inc Cancer Registry Software Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Rocky Mountain Cancer Data Systems (RMCDS) Corporate Information, Head Office, and Major Competitors
Table 11. Rocky Mountain Cancer Data Systems (RMCDS) Major Business
Table 12. Rocky Mountain Cancer Data Systems (RMCDS) Cancer Registry Software Product and Solutions
Table 13. Rocky Mountain Cancer Data Systems (RMCDS) Cancer Registry Software Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Electronic Registry Systems (ERS) Corporate Information, Head Office, and Major Competitors
Table 15. Electronic Registry Systems (ERS) Major Business
Table 16. Electronic Registry Systems (ERS) Cancer Registry Software Product and Solutions
Table 17. Electronic Registry Systems (ERS) Cancer Registry Software Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Mckesson Corporate Information, Head Office, and Major Competitors
Table 19. Mckesson Major Business
Table 20. Mckesson Cancer Registry Software Product and Solutions
Table 21. Mckesson Cancer Registry Software Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. C/Net Solutions Corporate Information, Head Office, and Major Competitors
Table 23. C/Net Solutions Major Business
Table 24. C/Net Solutions Cancer Registry Software Product and Solutions
Table 25. C/Net Solutions Cancer Registry Software Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Elekta AB Corporate Information, Head Office, and Major Competitors
Table 27. Elekta AB Major Business
Table 28. Elekta AB Cancer Registry Software Product and Solutions
Table 29. Elekta AB Cancer Registry Software Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Global Cancer Registry Software Revenue (USD Million) by Players (2019-2021)
Table 31. Global Cancer Registry Software Revenue Share by Players (2019-2021)
Table 32. Breakdown of Cancer Registry Software by Company Type (Tier 1, Tier 2 and Tier 3)
Table 33. Cancer Registry Software Players Head Office, Products and Services Provided
Table 34. Cancer Registry Software Mergers & Acquisitions in the Past Five Years
Table 35. Cancer Registry Software New Entrants and Expansion Plans
Table 36. Global Cancer Registry Software Revenue (USD Million) by Type (2016-2021)
Table 37. Global Cancer Registry Software Revenue Share by Type (2016-2021)
Table 38. Global Cancer Registry Software Revenue Forecast by Type (2021-2026)
Table 39. Global Cancer Registry Software Revenue by Application (2016-2021)
Table 40. Global Cancer Registry Software Revenue Forecast by Application (2021-2026)
Table 41. North America Cancer Registry Software Revenue by Type (2016-2021) & (USD Million)
Table 42. North America Cancer Registry Software Revenue by Type (2021-2026) & (USD Million)
Table 43. North America Cancer Registry Software Revenue by Application (2016-2021) & (USD Million)
Table 44. North America Cancer Registry Software Revenue by Application (2021-2026) & (USD Million)
Table 45. North America Cancer Registry Software Revenue by Country (2016-2021) & (USD Million)
Table 46. North America Cancer Registry Software Revenue by Country (2021-2026) & (USD Million)
Table 47. Europe Cancer Registry Software Revenue by Type (2016-2021) & (USD Million)
Table 48. Europe Cancer Registry Software Revenue by Type (2021-2026) & (USD Million)
Table 49. Europe Cancer Registry Software Revenue by Application (2016-2021) & (USD Million)
Table 50. Europe Cancer Registry Software Revenue by Application (2021-2026) & (USD Million)
Table 51. Europe Cancer Registry Software Revenue by Country (2016-2021) & (USD Million)
Table 52. Europe Cancer Registry Software Revenue by Country (2021-2026) & (USD Million)
Table 53. Asia-Pacific Cancer Registry Software Revenue by Type (2016-2021) & (USD Million)
Table 54. Asia-Pacific Cancer Registry Software Revenue by Type (2021-2026) & (USD Million)
Table 55. Asia-Pacific Cancer Registry Software Revenue by Application (2016-2021) & (USD Million)
Table 56. Asia-Pacific Cancer Registry Software Revenue by Application (2021-2026) & (USD Million)
Table 57. Asia-Pacific Cancer Registry Software Revenue by Region (2016-2021) & (USD Million)
Table 58. Asia-Pacific Cancer Registry Software Revenue by Region (2021-2026) & (USD Million)
Table 59. South America Cancer Registry Software Revenue by Type (2016-2021) & (USD Million)
Table 60. South America Cancer Registry Software Revenue by Type (2021-2026) & (USD Million)
Table 61. South America Cancer Registry Software Revenue by Application (2016-2021) & (USD Million)
Table 62. South America Cancer Registry Software Revenue by Application (2021-2026) & (USD Million)
Table 63. South America Cancer Registry Software Revenue by Country (2016-2021) & (USD Million)
Table 64. South America Cancer Registry Software Revenue by Country (2021-2026) & (USD Million)
Table 65. Middle East & Africa Cancer Registry Software Revenue by Type (2016-2021) & (USD Million)
Table 66. Middle East & Africa Cancer Registry Software Revenue by Type (2021-2026) & (USD Million)
Table 67. Middle East & Africa Cancer Registry Software Revenue by Application (2016-2021) & (USD Million)
Table 68. Middle East & Africa Cancer Registry Software Revenue by Application (2021-2026) & (USD Million)
Table 69. Middle East & Africa Cancer Registry Software Revenue by Country (2016-2021) & (USD Million)
Table 70. Middle East & Africa Cancer Registry Software Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Cancer Registry Software Picture
Figure 2. Global Cancer Registry Software Revenue Market Share by Type in 2020
Figure 3. Cloud-Based
Figure 4. On-Premise
Figure 5. Cancer Registry Software Revenue Market Share by Application in 2020
Figure 6. Hospitals Picture
Figure 7. Government Organizations Picture
Figure 8. Cancer Research Centers Picture
Figure 9. Others Picture
Figure 10. Global Cancer Registry Software Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Cancer Registry Software Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Cancer Registry Software Revenue Market Share by Region (2016-2026)
Figure 13. Global Cancer Registry Software Revenue Market Share by Region in 2020
Figure 14. North America Cancer Registry Software Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Cancer Registry Software Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Cancer Registry Software Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Cancer Registry Software Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Cancer Registry Software Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Cancer Registry Software Market Drivers
Figure 20. Cancer Registry Software Market Restraints
Figure 21. Cancer Registry Software Market Trends
Figure 22. Onco Inc Recent Developments and Future Plans
Figure 23. Rocky Mountain Cancer Data Systems (RMCDS) Recent Developments and Future Plans
Figure 24. Electronic Registry Systems (ERS) Recent Developments and Future Plans
Figure 25. Mckesson Recent Developments and Future Plans
Figure 26. C/Net Solutions Recent Developments and Future Plans
Figure 27. Elekta AB Recent Developments and Future Plans
Figure 28. Global Cancer Registry Software Revenue Share by Players in 2020
Figure 29. Cancer Registry Software Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 30. Global Top 3 Players Cancer Registry Software Revenue Market Share in 2020
Figure 31. Global Top 10 Players Cancer Registry Software Revenue Market Share in 2020
Figure 32. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 33. Global Cancer Registry Software Revenue Share by Type in 2020
Figure 34. Global Cancer Registry Software Market Share Forecast by Type (2021-2026)
Figure 35. Global Cancer Registry Software Revenue Share by Application in 2020
Figure 36. Global Cancer Registry Software Market Share Forecast by Application (2021-2026)
Figure 37. North America Cancer Registry Software Sales Market Share by Type (2016-2026)
Figure 38. North America Cancer Registry Software Sales Market Share by Application (2016-2026)
Figure 39. North America Cancer Registry Software Revenue Market Share by Country (2016-2026)
Figure 40. United States Cancer Registry Software Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Cancer Registry Software Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Cancer Registry Software Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Cancer Registry Software Sales Market Share by Type (2016-2026)
Figure 44. Europe Cancer Registry Software Sales Market Share by Application (2016-2026)
Figure 45. Europe Cancer Registry Software Revenue Market Share by Country (2016-2026)
Figure 46. Germany Cancer Registry Software Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Cancer Registry Software Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Cancer Registry Software Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Cancer Registry Software Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Cancer Registry Software Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Cancer Registry Software Sales Market Share by Type (2016-2026)
Figure 52. Asia-Pacific Cancer Registry Software Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Cancer Registry Software Revenue Market Share by Region (2016-2026)
Figure 54. China Cancer Registry Software Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Japan Cancer Registry Software Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. South Korea Cancer Registry Software Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. India Cancer Registry Software Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Southeast Asia Cancer Registry Software Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Australia Cancer Registry Software Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South America Cancer Registry Software Sales Market Share by Type (2016-2026)
Figure 61. South America Cancer Registry Software Sales Market Share by Application (2016-2026)
Figure 62. South America Cancer Registry Software Revenue Market Share by Country (2016-2026)
Figure 63. Brazil Cancer Registry Software Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Argentina Cancer Registry Software Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Middle East and Africa Cancer Registry Software Sales Market Share by Type (2016-2026)
Figure 66. Middle East and Africa Cancer Registry Software Sales Market Share by Application (2016-2026)
Figure 67. Middle East and Africa Cancer Registry Software Revenue Market Share by Country (2016-2026)
Figure 68. Turkey Cancer Registry Software Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Saudi Arabia Cancer Registry Software Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. UAE Cancer Registry Software Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Methodology
Figure 72. Research Process and Data Source